Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Formosa Laboratories is a leading Taiwan-based CDMO specializing in the development and manufacture of active pharmaceutical ingredients (APIs), high potency APIs, peptides, antibody-drug conjugates (ADCs), and injectable drug products. The company operates under cGMP standards with global regulatory approvals including US FDA, EU EDQM, Japan PMDA. It supplies dozens of commercial API products worldwide—especially vitamin D derivatives—and offers comprehensive custom synthesis services from process development to large-scale manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Formosa Laboratories.